| Literature DB >> 28634880 |
Abdelmjid Chraibi1,2, Shoorook Al-Herz3, Bich Dao Nguyen4, Djoko W Soeatmadji5, Anil Shinde6, Balasubramanian Lakshmivenkataraman7, Samir H Assaad-Khalil8.
Abstract
Entities:
Year: 2017 PMID: 28634880 PMCID: PMC5544612 DOI: 10.1007/s13300-017-0275-2
Source DB: PubMed Journal: Diabetes Ther Impact factor: 2.945
Fig. 3a Mean change from baseline FPG (LOCF); b 7-point SMPG profiles from baseline and after 20 weeks of treatment (EOT); c total daily insulin dose. Data from FAS. EOT end of trial, FPG fasting plasma glucose, LOCF last observation carried forward, SMPG self-measured plasma glucose